Tag: achillion

April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 1, 2018

5 Top NASDAQ Biotech Stocks: Cardiome on Top

Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices.
March 18, 2018

5 Top NASDAQ Biotech Stocks: Second Sight Medical on Top

Second Sight, Juniper, Athersys, Aptose and ArQule were last week's five top-gaining NASDAQ biotech stocks. See what moved their share...
March 4, 2018

5 Top NASDAQ Biotech Stocks: Tenax on top with a 51.94 Percent Increase

This past week the NASDAQ Biotechnology Index increased by 4.15 percent reaching 3,501.80 points in the last week—nearly equal to...
February 26, 2018

Positive Regulatory News from Two Pharmaceutical Companies Triggers Share Price Increases

Investors and analysts are focusing on KemPharm and Achillion after both companies received recent positive regulatory news.
February 18, 2018

5 Top NASDAQ Biotech Stocks: HTG in the Lead This Week

This past week the NASDAQ Biotechnology Index increased by 4.15 percent reaching 3,501.80 points in the last week—nearly equal to...
September 9, 2016

Achillion Announces Results of Janssen’s Phase 2a Trial

Achillion Pharmaceuticals announced today that new interim results from a phase 2a study being conducted by Alios BioPharma, part of...